Here’s a useful article covering industry developments in the AI x Bio space.
Faster drug discovery, optimized drug design, even programmable therapeutics: AI is impacting R&D. Data and development bottlenecks remain.
Get the latest international news and world events from around the world.
Meet EcoBOT: The Autonomous Lab Standardizing Plant-Microbe Research
To harness biological systems (plants and microbes) for next-generation energy production and advanced materials, researchers are looking to beneficial plant-microbe interactions. Because these are complex systems, it has proven difficult to reproducibly control exactly which microbes are present. And, subtle differences in materials, methods, or even the hands of the researchers themselves can lead to inconsistent results. This makes it difficult to replicate previous work, significantly slowing the leap from scientific discovery to practical application.
Researchers at Lawrence Berkeley National Laboratory (Berkeley Lab) are overcoming this bottleneck by addressing a multi-layered challenge: building reliable physical hardware, engineering accurate visual sensors, and developing predictive algorithms. Their solution, EcoBOT, stands out from typical plant phenotyping facilities by integrating these distinct components into a reliably automated workflow under strictly sterile conditions.
EcoBOT takes specialized growth chambers, called EcoFABs, and integrates them with machine-learning tools that autonomously guide the discovery cycle. This system uses advanced imaging to regularly scan the entire plant—from the tips of its leaves to the bottom of its roots. By using Gaussian Process models and AI analysis tools, it can quickly analyze and model this visual data to calculate the most informative next steps. This directs the automated hardware to determine exactly how plants adapt to environmental stressors, establishing the crucial microbe-free baseline needed to eventually study plant-microbe interactions and engineer better bioenergy crops.
Graphene can hold multiple states of superconductivity, a new study finds
The researchers discovered the multiple superconducting states in atomically thin exfoliations of graphite, known as graphene. Specifically, graphene is a single-atom-thin sheet of carbon atoms arranged precisely in a microscopic lattice. The team made its discoveries in samples of rhombohedral graphene, which is a natural structure within graphite consisting of a stack of four or five graphene layers.
Interestingly, the researchers found that several of the new superconducting states in rhombohedral graphene are able to persist in the presence of a magnetic field, which normally kills superconductivity.
And in a further surprise, these superconducting states even get stronger when exposed to a magnetic field.
Scientists discover an unexpected way to make pancreatic cancer cells self-destruct
Researchers tested experimental PCAI compounds against pancreatic cancer cells and found they had powerful anticancer effects. One leading compound blocked more than 90% of cancer cell migration, suggesting it could help prevent the spread of tumors. Rather than suppressing cancer signaling, the treatment hyperactivated key pathways until the cells essentially self-destructed.
Mpox (Monkeypox) Virus and Its Co-Infection with HIV, Sexually Transmitted Infections, or Bacterial Superinfections: Double Whammy or a New Prime Culprit?
Epidemiologic studies have established that mpox (formerly known as monkeypox) outbreaks worldwide in 2022–2023, due to Clade IIb mpox virus (MPXV), disproportionately affected gay, bisexual, and other men who have sex with men. More than 35% and 40% of the mpox cases suffer from co-infection with HIV and sexually transmitted infections (STIs) (e.g., Chlamydia trachomatis, Neisseria gonorrhoeae, Treponema pallidum, and herpes simplex virus), respectively. Bacterial superinfection can also occur. Co-infection of MPXV and other infectious agents may enhance disease severity, deteriorate outcomes, elongate the recovery process, and potentially contribute to the morbidity and mortality of the ensuing diseases. However, the interplays between MPXV and HIV, bacteria, other STI pathogens and host cells are poorly studied.
Cancer cell ‘degraders’ target two proteins at once to defeat treatment resistance
Researchers from two Technion faculties have jointly developed a new compound and demonstrated its effectiveness against aggressive tumor cells.
A study published in Oncogene presents an innovative strategy for the particularly complex medical challenge of destroying aggressive, treatment-resistant tumors.
The research was jointly led by early-career scientists Dr. Avital Oknin Vaisman and Dr. Deepanjan Panda from the laboratories of Prof. Amir Orian, head of the Rappaport Center for Cancer Research at the Technion-Israel Institute of Technology and a faculty member in the Ruth and Bruce Rappaport Faculty of Medicine, and Prof. Ashraf Brik of the Schulich Faculty of Chemistry.
The interplay between the microbiome and immune cells in metabolic homeostasis and disease
Shapiro et al. review how microbial signals modulate immune responses across tissues to regulate metabolic homeostasis and cardiometabolic diseases. They discuss mechanisms linking the microbiome, immunity, and tissue function and present emerging microbiome-based interventions for disease prevention and treatment.
WILL AI Turn Humanity Into BORG?
The Borg were never terrifying because they had advanced technology. They were terrifying because they erased individuality itself.
As brain-computer interfaces move from science fiction into reality, humanity may be approaching a question once reserved for Star Trek: What happens when technology no longer just helps us… but changes what it means to be human?
In this video, we explore the unsettling possibility that artificial intelligence, neural implants, and human enhancement technologies could eventually create something disturbingly similar to the Borg Collective.
🔹 Brain-computer interfaces and neural implants.
🔹 Human enhancement and transhumanism.
🔹 AI integration with the human mind.
🔹 Social and economic pressure to augment.
🔹 The loss of individuality and autonomy.
🔹 Whether technological evolution can be resisted.
If humanity could become smarter, faster, stronger, and more connected than ever before… would we resist? Or would we choose to become something else?
Resistance… may not be futile, but history suggests that enhancement rarely remains optional for long.
Genetic risk for Alzheimer’s disease could depend on how well you sleep
A compelling longitudinal study of over 350 older adults with early beta-amyloid accumulation reveals that the genetic risk for Alzheimer’s disease is not strictly deterministic, but is profoundly modulated by sleep quality through the AQP4 gene—a critical regulator of the brain’s glymphatic waste-clearance system. By cross-referencing specific AQP4 variants with multi-year MRI and PET imaging alongside cognitive assessments, researchers demonstrated that poor sleep parameters, such as shorter duration and delayed onset, significantly accelerate neurodegenerative markers like gray matter loss and ventricle expansion in carriers of specific risk alleles. Paradoxically, however, carriers of certain rare variants exhibited slower cognitive decline even in the presence of sleep disturbances. Ultimately, these findings illuminate a complex gene-environment interplay, proving that identical genetic predispositions can either expedite or buffer against brain atrophy depending on sleep architecture, thereby highlighting the critical necessity of personalized, sleep-targeted lifestyle interventions as a highly actionable strategy for Alzheimer’s prevention.
Scientists have discovered an important link between sleep, genetics, and Alzheimer’s disease. New findings suggest that getting poor sleep can accelerate brain shrinkage and memory loss in older adults carrying specific genetic variants.